On Wednesday, Lupin Pharmaceuticals recalled four lots of Quinapril Tablets because the medication has too much of the nitrosamine impurity N-Nitroso-Quinapril, the FDA announced.Quinapril Tablets USP, 20mg | lot No. G102929 | expiration date of April 2023Quinapril Tablets USP, 40mg | lot Nos. G100533, G100534, G203071 | expiration dates of December 2022 and March 2024
FDA announced Lupin Pharmaceuticals recalled four lots of Quinapril Tablets, a high blood pressure medication, due to a high amount of nitrosamine impurity. In October, Aurobindo Pharma recalled two lots of Quinapril because of the same nitrosamine impurity.What is nitrosamine and N-Nitroso-Quinapril?
However, impurities, like N-Nitroso-Quinapril, may increase the risk of cancer if people are exposed to it above acceptable levels over a long period of time.There have been no reports of illness from this recall, so consumers are not in immediate danger.